Market Trends of ELISpot And FluoroSpot Assay Industry
Assay Kits is Expected to Hold the Largest Market Share in the ELISpot and FluoroSpot Assay Market
- Assay kits play a vital role in a wide range of applications in life science research, drug development, and environmental monitoring. These applications include researching disease pathways, screening for prospective drug candidates, and evaluating biopharmaceutical production processes. The assay kits segment retains a dominant share owing to factors such as the high incidence of chronic ailments and increased use of these products for vaccine development in clinical studies.
- According to the American Society of Clinical Oncology's 2022 report, the United States witnessed an estimated 3,610 new cases of bone cancer and 2,060 deaths due to bone cancer in 2021. The prevalence of bone cancer and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and other conditions is estimated to drive the segment's growth as they are used in diagnosing these diseases.
- Moreover, the utility of assay kits in research activities and innovation in ELISpot assay kits is also expected to drive segment growth during the forecast period. For instance, a research study published in the Vaccines (Basel) Journal in December 2021 used an interferon-γ ELISpot assay on 38 kidney transplant recipients to detect serotype-specific cellular responses against S. pneumonia. Thus, the wide use of assays for research studies and clinical trials boosts the assay kit segment during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold a Significant Market Share Over the Forecast Period
- Due to several factors, North America is expected to dominate the ELISpot and FluoroSpot assay market throughout the forecast period. Firstly, there is a rising prevalence of cancer and infectious disease disorders in the region. The American Cancer Society's Cancer Statistics 2022 predicted that there would be 1,918,030 new cancer cases in the United States in 2022, including breast cancer, leukemia, and lymphoma.
- Moreover, data published by the American Academy of Pediatrics in March 2022 revealed that more than one million people in the United States have long-term hepatitis B infections, which can lead to chronic conditions such as liver cancer. This is expected to increase the demand for vaccines and drive the growth of ELISPOT assay, which is highly useful in studying infectious diseases.
- Secondly, technological advancements in test kits and analyzers for ELISpot and FluoroSpot are also contributing to the market growth. In September 2021, ImmunoSpot released SpotStat Software for statistical analysis of ELISPOT/FluoroSpot data. This software provides statistically validated differentiation between antigen-induced and negative controls, improving the accuracy of test results.
- Given these factors, the growth of the ELISpot and FluoroSpot assay market is anticipated in the North American region.
Get Analysis on Important Geographic Markets
Download PDF
